To Treat or Not to Treat: Assessing Risk and Treatment Options in High-Risk SMM

In this podcast episode, Natalie S. Callander, MD, and Tom Martin, MD, discuss the optimal approaches for the determination of whether a patient with high-risk SMM requires treatment or observation, including:

Contemporary Risk Stratification Interpreting Evidence for Early Intervention Treatment vs Observation: Patient Selection Treatment Selection and Sequencing Considerations Safety, Monitoring, and Supportive Care Implementation in Practice Shared Decision-making and Patient Communication Emerging Therapies and Clinical Trials

Presenters: 

Natalie S. Callander, MD
Professor of Medicine
Director, Myeloma Clinical and 
Cellular Therapy Program
University of Wisconsin Carbone 
Cancer Center
Madison, Wisconsin

Tom Martin, MD
Professor of Medicine
Associate Chief, Hematology/Oncology
UCSF Medical Center
San Francisco, California

Link to full program:
https://bit.ly/4wqpYzU

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.